UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)

Blood, 2009-10, Vol.114 (14), p.2984-2992

2009

Volltextzugriff (PDF)

Antihyperon-hyperon production in p¯p annihilations near the reaction thresholds

Nuclear physics. Section B, Proceedings supplement, 1997, Vol.56 (1), p.46-51

1997

Volltextzugriff (PDF)

Identification of N-(5-tert-Butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea Dihydrochloride (AC220), a Uniquely Potent, Selective, and Efficacious FMS-Like Tyrosine Kinase-3 (FLT3) Inhibitor

Journal of medicinal chemistry, 2009-12, Vol.52 (23), p.7808-7816

2009

Volltextzugriff (PDF)

Environmentally relevant concentrations of amine-functionalized copper nanoparticles exhibit different mechanisms of bioactivity in Fundulus Heteroclitus in fresh and brackish water

Nanotoxicology, 2017-10, Vol.11 (8), p.1070-1085

2017

Volltextzugriff (PDF)

Identification of 1-(3-(6,7-Dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea Hydrochloride (CEP-32496), a Highly Potent and Orally Efficacious Inhibitor of V-RAF Murine Sarcoma Viral Oncogene Homologue B1 (BRAF) V600E

Journal of medicinal chemistry, 2012-02, Vol.55 (3), p.1082-1105

2012

Volltextzugriff (PDF)

CEP-32496: a novel orally active BRAF(V600E) inhibitor with selective cellular and in vivo antitumor activity

Molecular cancer therapeutics, 2012-04, Vol.11 (4), p.930-941

2012

Volltextzugriff (PDF)

4-Quinazolinyloxy-diaryl ureas as novel BRAFV600E inhibitors

Bioorganic & medicinal chemistry letters, 2011-09, Vol.21 (18), p.5342-5346

2011

Volltextzugriff (PDF)

Bovine tuberculosis (Mycobacterium bovis) in British farmland wildlife: the importance to agriculture

Proceedings of the Royal Society. B, Biological sciences, 2006-02, Vol.273 (1584), p.357-365

2006

Volltextzugriff (PDF)

CEP-32496: A Novel Orally Active BRAFV600E Inhibitor with Selective Cellular and In Vivo Antitumor Activity

Molecular cancer therapeutics, 2012-04, Vol.11 (4), p.930-941

2012

Volltextzugriff (PDF)

Biphenyl-indanones: Allosteric potentiators of the metabotropic glutamate subtype 2 receptor

Bioorganic & medicinal chemistry letters, 2005-10, Vol.15 (19), p.4354-4358

2005

Volltextzugriff (PDF)

4-Quinazolinyloxy-diaryl ureas as novel BRAF super(V600E inhibitors)

Bioorganic & medicinal chemistry letters, 2011-09, Vol.21 (18), p.5342-5346

2011

Volltextzugriff (PDF)

3-[3-Fluoro-5-(5-pyridin-2-yl-2 H-tetrazol-2-yl)phenyl]-4-methylpyridine: a highly potent and orally bioavailable metabotropic glutamate subtype 5 (mGlu5) receptor antagonist

Bioorganic & medicinal chemistry letters, 2004-11, Vol.14 (22), p.5477-5480

2004

Volltextzugriff (PDF)

2-{2-[3-(Pyridin-3-yloxy)phenyl]-2 H-tetrazol-5-yl}pyridine: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonist

Bioorganic & medicinal chemistry letters, 2004-11, Vol.14 (22), p.5473-5476

2004

Volltextzugriff (PDF)

Impact of trapping and handling on Leukocyte Coping Capacity in bank voles ( Clethrionomys glareolus ) and wood mice ( Apodemus sylvaticus )

Animal welfare, 2009-02, Vol.18 (1), p.1-7

2009

Volltextzugriff (PDF)

Arabic heritage schools as sites of multilingualism and positive identity building in the UK

Community and Heritage Languages Schools Transforming Education, 2024, Vol.1, p.80-100

1, 2024

Volltextzugriff (PDF)

3-[Substituted]-5-(5-pyridin-2-yl-2 H-tetrazol-2-yl)benzonitriles: Identification of highly potent and selective metabotropic glutamate subtype 5 receptor antagonists

Bioorganic & medicinal chemistry letters, 2005-11, Vol.15 (22), p.5061-5064

2005

Volltextzugriff (PDF)

An Exploration of the Integration Challenges Inherent in the Adoption of ICT in an Education System

Information and Communication Technologies for Development, 2017, p.463-474

2017

Volltextzugriff (PDF)

Discovery of highly potent, selective, orally bioavailable, metabotropic glutamate subtype 5 (mGlu5) receptor antagonists devoid of cytochrome P450 1A2 inhibitory activity

Bioorganic & medicinal chemistry letters, 2004-11, Vol.14 (22), p.5481-5484

2004

Volltextzugriff (PDF)

Influence of acid surrogates toward potency of VLA-4 antagonist

Bioorganic & medicinal chemistry letters, 2005-09, Vol.15 (18), p.4053-4056

2005

Volltextzugriff (PDF)

2-(2-[3-(pyridin-3-yloxy)phenyl]-2H-tetrazol-5-yl) pyridine: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonist

Bioorganic & medicinal chemistry letters, 2004-11, Vol.14 (22), p.5473-5476

2004

Volltextzugriff (PDF)

ADHD: The diagnostic process from different perspectives

Journal of developmental and behavioral pediatrics, 2004-02, Vol.25 (1), p.53-57

STEIN, Martin T

2004

Volltextzugriff (PDF)

The Difference Between Activity When in Bed and Out of Bed. I. Healthy Subjects and Selected Patients

Chronobiology international, 1996, Vol.13 (1), p.27-34

1996

Volltextzugriff (PDF)

Unrecoverable? Prescriptions and Possibilities for Eating Disorder Recovery

Women's Mental Health, 2015, p.145-160

2015

Volltextzugriff (PDF)

3-[Substituted]-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitriles: Identification of Highly Potent and Selective Metabotropic Glutamate Subtype 5 Receptor Antagonists

ChemInform, 2006-02, Vol.37 (8), p.no-no

2006

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(27)

Publikationsform

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)

Antihyperon-hyperon production in p¯p annihilations near the reaction thresholds

Identification of N-(5-tert-Butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea Dihydrochloride (AC220), a Uniquely Potent, Selective, and Efficacious FMS-Like Tyrosine Kinase-3 (FLT3) Inhibitor

Environmentally relevant concentrations of amine-functionalized copper nanoparticles exhibit different mechanisms of bioactivity in Fundulus Heteroclitus in fresh and brackish water

Identification of 1-(3-(6,7-Dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea Hydrochloride (CEP-32496), a Highly Potent and Orally Efficacious Inhibitor of V-RAF Murine Sarcoma Viral Oncogene Homologue B1 (BRAF) V600E

CEP-32496: a novel orally active BRAF(V600E) inhibitor with selective cellular and in vivo antitumor activity

Climate research priorities for policy-makers, practitioners, and scientists in Georgia, USA

4-Quinazolinyloxy-diaryl ureas as novel BRAFV600E inhibitors

Bovine tuberculosis (Mycobacterium bovis) in British farmland wildlife: the importance to agriculture

CEP-32496: A Novel Orally Active BRAFV600E Inhibitor with Selective Cellular and In Vivo Antitumor Activity

Biphenyl-indanones: Allosteric potentiators of the metabotropic glutamate subtype 2 receptor

4-Quinazolinyloxy-diaryl ureas as novel BRAF super(V600E inhibitors)

3-[3-Fluoro-5-(5-pyridin-2-yl-2 H-tetrazol-2-yl)phenyl]-4-methylpyridine: a highly potent and orally bioavailable metabotropic glutamate subtype 5 (mGlu5) receptor antagonist

2-{2-[3-(Pyridin-3-yloxy)phenyl]-2 H-tetrazol-5-yl}pyridine: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonist

Impact of trapping and handling on Leukocyte Coping Capacity in bank voles ( Clethrionomys glareolus ) and wood mice ( Apodemus sylvaticus )

Arabic heritage schools as sites of multilingualism and positive identity building in the UK

3-[Substituted]-5-(5-pyridin-2-yl-2 H-tetrazol-2-yl)benzonitriles: Identification of highly potent and selective metabotropic glutamate subtype 5 receptor antagonists

An Exploration of the Integration Challenges Inherent in the Adoption of ICT in an Education System

Discovery of highly potent, selective, orally bioavailable, metabotropic glutamate subtype 5 (mGlu5) receptor antagonists devoid of cytochrome P450 1A2 inhibitory activity

Influence of acid surrogates toward potency of VLA-4 antagonist

2-(2-[3-(pyridin-3-yloxy)phenyl]-2H-tetrazol-5-yl) pyridine: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonist

ADHD: The diagnostic process from different perspectives

The Difference Between Activity When in Bed and Out of Bed. I. Healthy Subjects and Selected Patients

Unrecoverable? Prescriptions and Possibilities for Eating Disorder Recovery

3-[Substituted]-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitriles: Identification of Highly Potent and Selective Metabotropic Glutamate Subtype 5 Receptor Antagonists

Suchergebnisse filtern